This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Find ways to stay ahead in budgeting with routine reviews, alerts, and smart adjustments that protect your financial path.
21,896 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Costco reports solid membership-driven results in mid-2026, but the stock faces a high bar for growth and valuation. ...
NVIDIA's latest signals from Jensen Huang hint that AI chip demand remains robust. This article breaks down what that...
Two tech giants sit at the edge of a historic crown. This piece breaks down what would drive Apple about away from Nv...
A disappointing sale of 7-year notes underscores investor caution as Iran war fears rise. Traders point to a shifting...
The AI wave is accelerating, and savvy investors are looking for blue-chip names with durable AI catalysts. This guid...
The median age for first-time buyers climbed to a record 40, with Zillow’s chief executive warning relief from high c...
Wednesday brought a sharp move for Lemonade stock after a major bank downgraded the insurer. This article breaks down...
In a market eager for AI breakthroughs, one tech stock with eyes stands out as a long-term buy. This article breaks d...
XRP shows potential for a larger move as price predictions spark optimism, while Shiba Inu burns draw attention and E...
As Omnicom wraps up the 2025 fiscal year, investors want clarity on growth, margins, and capital allocation. This gui...
Unisys (UIS) 2026 earnings could hinge on services growth, margin discipline, and backlog strength. This guide breaks...